The Cut-off Values of Triglycerides - Glucose Index for Metabolic Syndrome Associated with Type 2 Diabetes Mellitus

Main Article Content

Ekhlas K. Hameed
Laith T. Al-Ameri
Hayder S. Hasan
Zina H. Abdulqahar


       The co-occurrence of metabolic syndrome with type 2 diabetes mellitus (T2DM) will potentiate the morbidity and mortality that may be associated with each case. Fasting triglycerides-glucose index (TyG index) has been recommended as a useful marker to predict metabolic syndrome. Our study aimed to introduce gender-specific cut-off values of triglycerides- glucose index   for diagnosing metabolic syndrome associated with type 2 diabetes mellitus. The data were collected from Baghdad hospitals between May - December 2019. The number of eligible participants was 424. National cholesterol education program, Adult Treatment Panel III criteria were used to define metabolic syndrome. Measurement of fasting blood glucose, lipid profile, HbA1c level, blood pressure, and anthropometric were done and the triglyceride-glucose index was calculated. Ethical approval and informed consent were obtained .SPSS was used to analyze the data. Diabetic patients with metabolic syndrome showed an increased level of TyG Index. The prevalence of metabolic syndrome increased with increased TyG index quartiles. The TyG-Index showed significant correlations with all components of metabolic syndrome. The optimal cut-off value revealed 9.14, 9.28 for males and females respectively. In conclusion, TyG index is a good predictor of the presence of MetS in T2DM the TyG index, just measured in one laboratory test, is simple, informative and more suitable for the detection of metabolic syndrome in Iraqi type 2 diabetes mellitus.


Download data is not yet available.

Article Details

How to Cite
Hameed EK, Al-Ameri LT, Hasan HS, Abdulqahar ZH. The Cut-off Values of Triglycerides - Glucose Index for Metabolic Syndrome Associated with Type 2 Diabetes Mellitus. Baghdad Sci.J [Internet]. 2022Apr.1 [cited 2022Jun.26];19(2):0340. Available from:


Tune J, Goodwill A, Sassoon D, Mather K. Cardiovascular consequences of metabolic syndrome. TRANSL RES. 2017;183:57-70.

Al Azzawi O. Metabolic Syndrome; comparing the results of three definition criteria in an Iraqi sample. Al-Kindy Col. Med. J. 2018;14(2):7–14.

Ahsan F. Metabolic Syndrome: mini Review. JSM Human Nutri Food Sc. 2019;5:6.

Salehinia F, Abdi H, Hadaegh F, Serahati S, Valizadeh M, Azizi F, et al. Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study. Diabetes Res Clin Pract. 2018;144:17-24.

Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, et al. The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. J Clin Endocrinol Metab. 2010;95(7):3347-3351.

Kim M, Ahn C, Kang S, Nam J, Kim K, Park J. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017;16(1):108.

Khan S, Sobia F, Niazi N, Manzoor S, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab. 2018;10(1).

Kim J, Park S, Kim Y, Im M, Han H. The cutoff values of indirect indices for measuring insulin resistance for metabolic syndrome in Korean children and adolescents. Ann Pediatr Endocrinol Metab. 2016;21(3):143.

American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes care. 2018 Jan 1;41(Supplement 1):S13-27.

Li W, Wang D, Wang X, Gong Y, Cao S, Yin X, et al. The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project. BMC Public Health. 2019;19(1):192.

Misra A, Dhurandhar N. Current formula for calculating body mass index is applicable to Asian populations. NUTR DIABETES. 2019;9(1).

Herath H, Weerasinghe N, Weerarathna T, Amarathunga A. A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions. Int. J. Chronic Dis. 2018;2018:1-8.

Lee EY, Yang HK, Lee J, Kang B, Yang Y, Lee SH, et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 2016;15(1-7).

Simental-Mendía L, Rodríguez-Morán M, Guerrero-Romero F. The Product of Fasting Glucose and Triglycerides As Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metab Syndr Relat Disord. 2008;6(4):299-304.

Abbasi F, Reaven G. Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism. 2011;60(12):1673-1676.

Kahn A, Allen J, Seidel C, Zhang S. Insulin Inhibits Migration of Vascular Smooth Muscle Cells With Inducible Nitric Oxide Synthase. Hypertension. 2000;35(1):303-306.

DeFronzo R. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus. Diabetes. 2009;58(4):773-795.

Moon S, Park J, Ahn Y. The Cut-off Values of Triglycerides and Glucose Index for Metabolic Syndrome in American and Korean Adolescents. J KOREAN MED SCI. 2017;32(3):427.

Osei-Yeboah J, Owiredu WK, Norgbe GK, Yao Lokpo S, Gyamfi J, Alote Allotey E, et al. The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana: A Cross-Sectional Study. Int. J. Chronic Dis. 2017;2017:1-8.

Agyemang-Yeboah F, Eghan B, Annani-Akollor M, Togbe E, Donkor S, Oppong Afranie B. Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana. Biomed Res. Int. 2019;2019:1-8.